Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
U.S. News & World Report4 天
Google-Backed AI Drug Discovery Startup Raises $600 Million
Google-Backed AI Drug Discovery Startup Raises $600 Million (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
GlobalData on MSN4 天
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
DATAQUEST3 天
Google DeepMind releases TxGemma: Open AI Models for Drug Discovery
Google DeepMind launches TxGemma, open AI models to speed up drug discovery, enhance predictions, and support multi-step ...
GEN - Genetic Engineering and Biotechnology News4 天
DeepMind Spinout Isomorphic Labs Raises $600M Toward AI Drug Design
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Google’s DeepMind Tightens AI Research Release amid AI Competition
AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...
Fierce Biotech4 天
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...